Abstract
This chapter is dedicated on nanovesicles for ocular drug delivery. It is well known that ocular delivery of drugs has several limitations because of various types of biological barriers encountered following topical delivery, and/or the potential toxicities, risks or implications, following delivery to the eye by invasive administration routes, such as intravitreal injections.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
